BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Costa CP, Cunha S, Moreira JN, Silva R, Gil-Martins E, Silva V, Azevedo L, Peixoto AF, Sousa Lobo JM, Silva AC. Quality by design (QbD) optimization of diazepam-loaded nanostructured lipid carriers (NLC) for nose-to-brain delivery: Toxicological effect of surface charge on human neuronal cells. Int J Pharm 2021;607:120933. [PMID: 34324988 DOI: 10.1016/j.ijpharm.2021.120933] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Elhabak M, Salama AAA, Salama AH. Nose-to-brain delivery of galantamine loaded nanospray dried polyacrylic acid/taurodeoxycholate mixed matrix as a protective therapy in lipopolysaccharide-induced Alzheimer's in mice model. Int J Pharm 2023;632:122588. [PMID: 36623740 DOI: 10.1016/j.ijpharm.2023.122588] [Reference Citation Analysis]
2 Correia AC, Monteiro AR, Silva R, Moreira JN, Sousa Lobo JM, Silva AC. Lipid nanoparticles strategies to modify pharmacokinetics of central nervous system targeting drugs: Crossing or circumventing the blood-brain barrier (BBB) to manage neurological disorders. Adv Drug Deliv Rev 2022;189:114485. [PMID: 35970274 DOI: 10.1016/j.addr.2022.114485] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Zafar A, Awad Alsaidan O, Alruwaili NK, Sarim Imam S, Yasir M, Saad Alharbi K, Singh L, Muqtader Ahmed M. Formulation of intranasal surface engineered nanostructured lipid carriers of rotigotine: Full factorial design optimization, in vitro characterization, and pharmacokinetic evaluation. Int J Pharm 2022;:122232. [PMID: 36155794 DOI: 10.1016/j.ijpharm.2022.122232] [Reference Citation Analysis]
4 Yasir M, Zafar A, Noorulla KM, Tura AJ, Sara UVS, Panjwani D, Khalid M, Haji MJ, Gobena WG, Gebissa T, Dalecha DD. Nose to brain delivery of donepezil through surface modified NLCs: Formulation development, optimization, and brain targeting study. Journal of Drug Delivery Science and Technology 2022. [DOI: 10.1016/j.jddst.2022.103631] [Reference Citation Analysis]
5 Nižić Nodilo L, Perkušić M, Ugrina I, Špoljarić D, Jakobušić Brala C, Amidžić Klarić D, Lovrić J, Saršon V, Safundžić Kučuk M, Zadravec D, Kalogjera L, Pepić I, Hafner A. In situ gelling nanosuspension as an advanced platform for fluticasone propionate nasal delivery. Eur J Pharm Biopharm 2022:S0939-6411(22)00081-9. [PMID: 35489667 DOI: 10.1016/j.ejpb.2022.04.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Durgun ME, Mesut B, Hacıoğlu M, Güngör S, Özsoy Y. Optimization of the Micellar-Based In Situ Gelling Systems Posaconazole with Quality by Design (QbD) Approach and Characterization by In Vitro Studies. Pharmaceutics 2022;14:526. [DOI: 10.3390/pharmaceutics14030526] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Noorulla K, Yasir M, Muzaffar F, S R, Ghoneim MM, Almurshedi AS, Tura AJ, Alshehri S, Gebissa T, Mekit S, Ahmed MM, Zafar A. Intranasal delivery of chitosan decorated nanostructured lipid carriers of Buspirone for brain targeting: Formulation development, optimization and In-Vivo preclinical evaluation. Journal of Drug Delivery Science and Technology 2022;67:102939. [DOI: 10.1016/j.jddst.2021.102939] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]